Type 2 & other diabetes

Blood-Based DNA Methylation Models Improve Short-term Cardiovascular Risk Stratification in Individuals With Type 2 Diabetes

Diabetes CarePublished Prognostic model development study

Authors' conclusion

The DNAm-based models we have generated may improve risk stratification for short-term cardiovascular events in individuals with T2DM, providing a promising approach to refine identification of those at increased risk of MACE.

Study context

Population
T2D participants of the TOSCA.IT study; DNA methylation (DNAm) profiled in peripheral blood mononuclear cells at baseline
Participants
305 participants
Comparison
Participants with major adverse cardiovascular events (MACE) within 5 years vs without
  • T2DMACEn = 81
  • T2Dn = 224reference
Outcome
Discriminative performance of DNAm-based models for incident MACE
Follow-up
5 years
Methodological detailsnested in the TOSCA.IT trial, epigenome-wide DNA methylation profiling, least absolute shrinkage and selection operator (LASSO) logistic regression with stability selection, random split into training and internal test sets, five covariate-adjustment frameworks
  • Nested in the TOSCA.IT trial
  • Epigenome-wide DNA methylation profiling
  • LASSO logistic regression with stability selection
  • Random split into training and internal test sets
  • Five covariate-adjustment frameworks

Performance

As reported in the abstract

Discrimination of five DNAm-based models in internal test cohort

ROC AUC range

0.915 to 0.937

Area under the precision-recall curve range

0.866 to 0.940

Further findings

Differentially methylated CpG sites across five frameworks

Differentially methylated CpG sites
23,839, 21,529, 21,500, 12,114, and 7,101
CpG predictors retained per model
22-26
CpGs identified across all models, independently associated with MACE risk
12

Original publication

Blood-Based DNA Methylation Models Improve Short-term Cardiovascular Risk Stratification in Individuals With Type 2 Diabetes. Diabetes Care. Published 16 July 2026. doi:10.2337/dc26-0738

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.